" class="no-js "lang="en-US"> Sajid Javid Archives - Page 3 of 5 - Medtech Alert
Saturday, September 13, 2025

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

NHS Opens Online Covid-19 Vaccination Bookings For 12-15 Year Olds

Parents will be able to book covid-19 vaccinations online for their 12-15 year old children […]

UK Government Secures Groundbreaking COVID-19 Antivirals

Thousands of vulnerable patients could be taking ground-breaking COVID-19 antivirals this winter after the government […]

NHS Delivers Over Three Million COVID Boosters in First Month

More than three million top up COVID-19 jabs have been delivered in just four weeks, […]

Lateral Flow Tests to be Introduced for Vaccinated International Arrivals

Eligible fully vaccinated passengers arriving in England from countries not on the red list can […]

Blood Donation to be Made More Inclusive

People who want to donate blood, particularly Black African donors, will be able to do […]

NHS Announces Deal for Life Changing Sickle Cell Treatment

The first treatment for sickle cell disease in over 20 years will be rolled out […]

Health Secretary has Genome Sequenced for Project Tackling Health Disparities

Health and Social Care Secretary Sajid Javid visited Great Ormond Street Hospital today to provide […]

Over One Million Invited For Covid Booster Jabs This Week

Invitations to book a Covid booster jab will be sent to one and a half […]

NHS Begins Covid-19 Booster Vaccination Campaign

The NHS has started delivering Covid booster jabs to people in eligible groups from today, […]

Innovation and New Technology to Help Reduce NHS Waiting Lists

Local surgical hubs, new technology to speed up diagnosis, and innovative ways of working will […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more